Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)
We SCAN! – INCA Launches First-Ever Global Survey to Measure Access Challenges to Optimal Neuroendocrine Tumor Care
In order to better understand the challenges of optimal care for neuroendocrine tumor (NET) patients, the International Neuroendocrine Cancer Alliance (INCA), of which the Carcinoid Cancer Foundation is a proud member, today launches SCAN –…
READ MORENew York City Luncheon with the Experts on NET Cancer Day 2019
Join neuroendocrine tumor (NET) patients in New York City on Sunday, November 10, 2019 — NET Cancer Day — for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear…
READ MORE
Let’s Talk About NET Survivorship: An Evening for Neuroendocrine Cancer Patients and Caregivers
“Let’s Talk About NET Survivorship!” is a special evening presentation on Friday, June 28 for neuroendocrine cancer patients and caregivers and their health care providers. Attend in person at the Grand Hotel Minneapolis in Minneapolis, Minnesota…
READ MORE
Facebook Live Event Featuring Carcinoid Heart Disease Specialist Dr. Jerome Zacks, May 17
Join us this Friday, May 17th at 2:00 pm EST, for a special Facebook Live event! We’ll hear from neuroendocrine tumor (NET) expert Dr. Jerome S. Zacks, a cardiologist, during an in-depth discussion about Carcinoid Heart Disease.
Dr. Zacks has extensive…
READ MORE
Twitter Can Help Neuroendocrine Tumor Patients Understand Pathology
While the downsides of social media are getting a lot of attention in the news, we shouldn’t forget the technology’s incredible power to share useful information efficiently to all who need it. Enter Raul S. Gonzalez, MD, a pathologist at Beth Israel Deaconess…
READ MORE
Promising Developments in the Pipeline for High Grade Neuroendocrine Tumor Diagnosis and Treatment
“Treatment for high grade neuroendocrine neoplasms (abnormal tissue growth) is moving the way that the treatment for triple negative breast cancer is moving — toward the realization that there are a basket of subtypes and that each can be potentially…
READ MORE
Cytoreductive Surgery: Why, When, & How often?
The Carcinoid Cancer Foundation recently presented a Live Q&A session with Dr. Xavier Keutgen, discussing surgery for people living with neuroendocrine…
READ MORE
Markey Cancer Center to Host OncLive Summit on Neuroendocrine Tumors
The UK Markey Cancer Center in Lexington, Kentucky, will host OncLive’s State of the Science Summit on Neureoendocrine Tumors (NETs) on Saturday, April 20, 2019. The Summit is “designed to educate healthcare professionals on the clinical benefits …
READ MORE CCF Presents Facebook Live with NET Expert Xavier Keutgen, MD – March 18 at 12 Noon, EST
You are invited to attend a CCF Facebook Live event with Xavier Keutgen, MD on Monday, March 18 at 12 noon, Eastern Standard Time. Dr. Keutgen, a surgical oncologist with particular expertise in treating neuroendocrine, thyroid, parathyroid and adrenal…
READ MORE
Please Help Pass a Bill That Could Result in Earlier Diagnosis for Neuroendocrine Cancer Patients
NET patients, friends and families – we need your help! Greta Stifel, founder of the Stifle Cancer Foundation, NET patient thriver, advocate and political activist, has created and submitted to the State of Connecticut Public Health Committee,…
READ MORE
